Cicletanine (HCl)
Overview
Dabrafenib mesylate is a kinase inhibitor. The chemical name for dabrafenib mesylate is N-{3- [5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-
difluorobenzene sulfonamide, methanesulfonate salt. it is used for the treatment of patients with unresectable or metastatic melanoma with braf V600E mutation.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Cicletanine (HCl)'s dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 50 to 100 mg | 75 (75) | 24 hourly | | |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Cicletanine (HCl) is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Cicletanine (HCl) is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
No data regarding the pathological interferences produced by Dabrafenib is available.
Back to top
Brands / Trade Names of
Cicletanine (HCl)
Back to top
Manufacturers of
Cicletanine (HCl)
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic